Ra Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference

May 1, 2018 |

1 min read

Ra Pharmaceuticals, Inc. announced that Doug Treco, Ph.D., President and Chief Executive Officer, will present at the Deutsche Bank 43rd Annual Health Care Conference on Tuesday, May 8, 2018 at 10:00 a.m. E.T.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ra Pharmaceuticals (NASDAQ:RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced that Doug Treco, Ph.D., President and Chief Executive Officer, will present at the Deutsche Bank 43^rd Annual Health Care Conference on Tuesday, May 8, 2018 at 10:00 a.m. E.T. The conference is being held at the InterContinental Boston.

A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of the presentation will also be available and archived on the site for three weeks.

About Ra Pharmaceuticals

Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180501005119/en/

Contacts

Investors:
Ra Pharmaceuticals, Inc.
Jennifer Robinson, 617-674-9873
jrobinson@rapharma.com
or
Media:
Argot Partners
David Rosen, 212-600-1902
david.rosen@argotpartners.com

Source: Ra Pharmaceuticals, Inc.

Events